In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.
Although the immunotherapy plus chemotherapy did not improve disease-free survival (DFS) in newly diagnosed, high-risk patients with endometrial cancer, the combination therapy did improve DFS for patients...
A first-time analysis using the National Inpatient Sample (NIS) database sought to examine the relationship between polycystic ovary syndrome (PCOS) and gynecologic cancers, including endometrial cancer.
...
In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
In April, the Society of Radiologists in Ultrasound released a consensus statement outlining recommendations for healthcare providers with the goal of improving the imaging, detection, and evaluation of...
Gynecologic oncologists currently lack risk models that can accurately predict an endometrial cancer diagnosis at the time of hysterectomy for endometrial intraepithelial neoplasia. To fill this gap,...
This COVID-19 roundup includes coverage of the latest and final COVID-19 treatment guidelines by the NIH, the effectiveness of the COVID-19 vaccine in preventing pediatric long COVID, the spring 2024...
Researchers developed a retrospective cohort study to examine the reoperation rates and health care costs associated with reoperation for patients who underwent breast-conserving surgery.
